Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06337734 · ClinicalTrials.gov registry record · NA

An Artificial Intelligence-Assisted Digital Health Lifestyle Intervention for Adults With Hypertension

A NA study, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
141
Enrollment target

NCT06337734: Completed NA study, sponsored by University of California, San Diego.

NCT06337734 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 141 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06337734, a NA study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
141 participants
Enrollment target

Study Summary

This study evaluates the impact of a fully digital, autonomous, and artificial intelligence (AI)-driven lifestyle coaching program on managing blood pressure (BP) among adults diagnosed with hypertension. Participants received a BP monitor and a wearable activity tracker to facilitate data collection. This data, along with responses from a questionnaire mobile app, were analyzed by an automated analytics engine employing statistical and machine learning techniques. The program delivered tailored lifestyle coaching directly to participants through a mobile app, aiming for precise and effective BP management.

Interventions

  • BEHAVIORAL AI-Driven Lifestyle Coaching Program

Trial Details

FieldValue
Enrollment Target 141 participants
Start Date 2021-11-01
Est. Completion 2023-08-01
Phase NA
University of California, San Diego

775 total trials

What the finished NCT06337734 record still lists

NCT06337734 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which AI-Driven Lifestyle Coaching Program is the first listed.

NCT06337734 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06337734 about?

NCT06337734 is a clinical study titled "An Artificial Intelligence-Assisted Digital Health Lifestyle Intervention for Adults With Hypertension". This study evaluates the impact of a fully digital, autonomous, and artificial intelligence (AI)-driven lifestyle coaching program on managing blood pressure (BP) among adults diagnosed with hypertension. Participants received a BP monitor and a wearable activity tracker to facilitate data collectio...

What is the current status of trial NCT06337734?

This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2021-11-01. Estimated completion is 2023-08-01.

What interventions are being tested in trial NCT06337734?

The interventions under investigation include: AI-Driven Lifestyle Coaching Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06337734?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06337734's enrollment target sits among peer trials

141 712th of 2000 higher than 1,288 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03042962 · 141 participants

    Brain Networks in Dystonia

  • NCT04378439 · 141 participants · NA

    Appalachian Partnership to Reduce Disparities (Aim 2)

  • NCT04775485 · 141 participants · Phase 2

    A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

  • NCT05040360 · 141 participants · Phase 2

    Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06337734, the US trial registry maintained by the National Library of Medicine. NCT06337734 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.